In a recent paper in BMT, Corbacioglu et al 1 reported the results of a retrospective multicenter study on defibrotide (DF) treatment of children with hepatic veno-occlusive disease (VOD). An important finding was that an increased delay from the diagnosis of VOD to the start of DF treatment was significantly associated with a worse outcome, that is, absence of complete response (defined as resolution of VOD-and multiorgan failure-related symptoms together with a bilirubin decrease to o34.2 mmol/l (2 mg/dl)).
A multivariate logistic regression analysis 2 was performed to search for significant associations of possible predicting factors with outcome after adjustment for other factors. Although not explicitly stated in the paper, the usual asymptotic logistic regression approach based on parametric assumptions was obviously used, since 'owing to the small patient number, multivariate analyses on all variables were not possible'. Logistic regression modeling was thus restricted to two parameters of high clinical relevance, the dose of DF and the delay to start of treatment. The logistic regression analysis revealed the delay to start of treatment as the only significant predictor of outcome. In the discussion section, the authors state that 'a bias in the comparison of patients who received different timing and dose of DF cannot be excluded. With sufficient numbers of patients, a multivariate analysis would be possible and take clinical differences between patients into account'.
It is not possible to increase the numbers of patients to be studied without considerable effort. However, there is a way to optimize statistical analysis in this situation with a method especially developed for small data sets and/or skewed data: exact logistic regression, 3 which is a scientifically well founded but not widely known statistical method. In settings where conventional asymptotic logistic regression does not work any more or even produces incorrect results, exact logistic regression models often can be constructed and do not produce incorrect findings. This method is implemented in commercially available software, the results presented here were computed using LogXact 5.0 (CYTEL Software Corporation, Cambridge MA, USA). When applying the exact logistic regression method to the data presented in the paper by Corbacioglu et al, we tried to construct a logistic regression model including all variables significantly (Po0.05) associated with the outcome in univariate exact logistic regression analyses. These variables were: (1) delay to start of treatment (Po0.001), (2) severe vs mild/moderate VOD (Po0.001), (3) averaged daily DF dose per body weight (P ¼ 0.006), and (4) conditioning regimens with busulfan and cyclophosphamide and/or melphalan vs all other conditioning regimens (P ¼ 0.029). The construction of a model including all four variables was not possible. Therefore, variables were included into the exact logistic regression model in a forward stepwise manner, 2 resulting in models with variable 1, variables 1 plus 4, and the final model with variables 1 plus 3 plus 4. See Table 1 for the comparison of results of the asymptotic logistic regression model described by Corbacioglu et al and the exact logistic regression model we calculated with their data. There are three important differences: First, delay to start of treatment remains the most important predictor of outcome, but the evidence of its importance is improved because this result is adjusted by two instead of zero other variables. Second, averaged daily DF dose per body weight is an independently significant predictor of outcome, which was wrongly denied by asymptotic logistic regression. Third, the conditioning regimen is also an independently significant predictor of outcome, a fact not accessible by asymptotic logistic regression.
In conclusion, the application of exact logistic regression, as implemented in commercially available software, has confirmed the main message of the paper of Corbacioglu et al, that delaying the start of DF treatment is associated with a bad prognosis. It has made it possible to strengthen this message by demonstrating that this influence is independent of other important factors, without the need to increase the number of patients studied. And it has highlighted two new aspects for the prediction of outcome in pediatric VOD patients treated with DF. The application of this and of other exact statistical methods is encouraged 
